In October 2015 the French Anti-Doping Agency (AFLD) reported an anti-doping rule violation against the cyclist after his sample tested positive for the prohibited substances Prednisolone and Prednisone. Following notification the Athlete filed a statement in his defence.

The Athlete admitted the violation and denied the intentional use of the substances. He explained with evidence that he suffered from bronchitis and had used Prednisolone tablets he already had available from a previous prescription.

The AFLD determines that:

• The Athlete committed an anti-doping rule violation;
• He acted negligently with his self-medication.;

Therefore the AFLD decides on 2 March 2016 to impose a 1 year period of ineligibility on the Athlete.

On 25 August 2015 the French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (FFHMFAC) Disciplinary Panel decided to impose a 3 year period of ineligibility on the bodybuilder after his sample tested positive for the prohibited subsances Furosemide, Metandienone and Methyltestosterone.

Hereafter the case against the Athlete was reopened by the AFLD. Following notification the Athlete admitted the intentional use of these substances.

The AFLD determines:

• The Athlete had committed an anti-doping rule violation;
• He admitted the intentional use of these substances.

Therefore the AFLD decides on 17 February 2016 to impose a 4 year period of ineligibility on the Athlete.

On 25 August 2015 the French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (FFHMFAC) Disciplinary Panel decided to impose a 2 year period of ineligibility on the bodybuilder after he tested positive for the prohibited substance Stanozolol.

Hereafter the case against the Athlete was reopened by the AFLD. Following notification the Athlete filed a statement in his defence.

The Athlete denied the intentional use of Stanozolol and could not explain how the substance had entered his system. He assumed that his supplements were the source of the positive test.

The AFLD determines that:

• The Athlete had committed an anti-doping rule violation;
• He failed to establish that the violation was not intentional.

Therefore the AFLD decides on 17 February 2016:

• To uphold the FFHMFAC Disciplinary Panel decision for the imposition of a 2 year ban on the Athlete; and
• To extend the sanction for application with other relevant French sports federations.

In June and in July 2015 the French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (FFHMFAC) reported two anti-doping rule violations against the bodybuilder.

The Athlete had provided samples on 2 May 2015 and on 30 May 2015 and the FFHMFAC was informed that the presence had been established in these samples of multiple prohibited substances:

• Boldenone;
• Bumetanide;
• Salbutamol;
• Stanozolol;
• Tamoxifen;
• Trenbolone.

Consequently the FFHMFAC Disciplinary Panel decided on 30 June 2015 to impose a 4 year period of ineligibility on the Athlete regarding his first positive test of 2 May 2015. 

On 25 August 2015 the FFHMFAC Disciplinary Panel decided to extent the current sanction of 4 years to a 6 year period of ineligibility because of his second positive test of 30 May 2015 as second anti-doping rule violation.

Hereafter the French Anti-Doping Agency (AFLD) reopened the cases against the Athlete. Following notification the Athlete admitted the intentional use of the substances.

The AFLD determines that:

• The Athlete had intentionally committed multiple anti-doping rule violations;
• The FFHMFAC had opened separate disciplinary proceedings against the Athlete following the 2 positive test results;
• The FFHMFAC had erroneously applied the anti-doping rules regarding the second anti-doping rule violation;
• Both anti-doping rule violations must be considered as one single anti-doping rule violation;
• Aggravating circumstances are no justification for the imposition of a 6 year period of ineligibility.

Therefore the AFLD decides on 17 February 2016 to reform the FFHMFAC decisions and to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension.

In June and in July 2015 the French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (FFHMFAC) reported two anti-doping rule violations against the bodybuilder.

The Athlete had provided samples on 18 April 2015 and on 30 May 2015 and the FFHMFAC was informed that the presence had been established in these samples of multiple prohibited substances:

• 19-norandrosterone (Nandrolone);
• Clenbuterol;
• Clomifene;
• Metandienone;
• Stanozolol;
• Tamoxifen;

Consequently the FFHMFAC Disciplinary Panel decided on 30 June 2015 to impose a 4 year period of ineligibility on the Athlete regarding his first positive test of 18 April 2015. 

On 25 August 2015 the FFHMFAC Disciplinary Panel decided to extent the current sanction of 4 years to a 6 year period of ineligibility because of his second positive test of 30 May 2015 as second anti-doping rule violation.

Hereafter the French Anti-Doping Agency (AFLD) reopened the cases against the Athlete. Following notification the Athlete failed to file statement in his defence.

The AFLD determines that:

• The Athlete had intentionally committed multiple anti-doping rule violations;
• The FFHMFAC had opened separate disciplinary proceedings against the Athlete following the 2 positive test results;
• The FFHMFAC had erroneously applied the anti-doping rules regarding the second anti-doping rule violation;
• Both anti-doping rule violations must be considered as one single anti-doping rule violation;
• Aggravating circumstances are no justification for the imposition of a 6 year period of ineligibility.

Therefore the AFLD decides on 17 February 2016 to reform the FFHMFAC decisions and to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension.

On 18 August 2015 the Disciplinary Panel of the French Federation for Kick Boxing, Muay Thai and Associated Disciplines (FFKMDA) decided to impose a 9 month period of ineligibility on the Muathai Athlete for his evasion, refusal or failure to submit to sample collection.

The Doping Control Officers reported that at the Doping Control Center in June 2015 the Athlete was unable to produce enough urine for a sample. Although the Athlete was instructed to come back later for an additional sample he failed to return to the Doping Control Center.

Hereafter the case against the Athlete was reopened by the AFLD. Following notification the Athlete filed a statement in his defence.

The Athlete denied that he acted intentionally and  acknowledged that he had been instructed to return to provide an additional sample. On the advice of his coach he left the venue because of the threatening behaviour of his opponent's entourage wheras het forgot to return to the Doping Control Center.

The Athlete confirmed that he was contacted by his coach at his home to return to the Doping Control. Yet, he did not comply and remained at his home because of his fatigue.

The AFLD determines that:

• The Athlete had committed an anti-doping rule violation;
• He had no compelling justification for his evasion, refusal or failure to submit to sample collection.

Therefore the AFLD decides on 17 February 2016 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspenion, i.e. on 22 July 2015.

On 26 June 2015 the French Federation for Kick Boxing, Muay Thai and Associated Disciplines (FFKMDA) Disciplinary Panel decided to impose a 1 year period of ineligibility on the Muaythai Athlete for his refusal or failure to submit to sample collection.

The Doping Control Officers reported that at the Doping Control Center in February 2015 the Athlete was unable to produce enough urine for a sample. Although the Athlete was instructed to come back later for an additional sample he failed to return to the Doping Control Center.

Hereafter the case against the Athlete was reopened by the AFLD. Following notification the Athlete failed to respond.

The AFLD determines that:

• The Athlete had committed an anti-doping rule violation;
• He deliberately had refused to provide a sample;
• He failed to respond and accordingly failed to file a statement in his defence.

Therefore the AFLD decides on 17 February 2016 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 8 February 2015.

On 17 November 2015 the French Federation of Workers and Amateurs in Sports (FSGT) Appeal Panel decided to impose a 2 year period of ineligibility on the cyclist after his A and B samples tested positive for the prohibited substances 19-norandrosterone and 19-noretiocholanolone (Nandrolone).

Thereupon the French Anti-Doping Agency (AFLD) reopened the case against the Athlete. Following notification the Athlete filed a statement in his defence and he was heard.

The Athlete denied the intentional use of the substances and asserted that his prostate cancer could explain the positive test results. Further he disputed the bad conditions for sample collection at the competititon and insisted that his B sample should be analysed in another accredited laboratory.

The AFLD determines that:

• The Athlete committed an anti-doping rule violation;
• He failed to demonstrate with corroborating evidence that his medical condition could explain the positive test results;
• Only intentional use could explain the high concentration Nandrolone metabolites established in his samples; 
• The circumstances at the competition were approprate enough for sample collection;
• Under the Rules the A and B samples must be analysed in the same laboratory.

Therefore the AFLD decides on 3 February 2016:

• To uphold the FSGT Appeal Panel decision for the imposition of a 2 year ban on the Athlete; and
• To extend the sanction for application with other relevant French sports federations.

In August 2015 the French Anti-Doping Agency (AFLD) reported an anti-doping rule violation against the Athlete after her sample tested positive for the prohibited substances Prednisolone and Prednisone. Following notification the Athlete filed a statement in her defence.

The Athlete admitted the violation and denied the intentional use of the substances. She explained with evidence that she underwent medical treatment for her Asthma and that she had used Solupred tablets (Prednisone) prescribed by her doctor.

The AFLD determines that:

• The Athlete committed an anti-doping rule violation;
• She underwent legitimate medical treatment for her condition;
• There was a medical justification for the prescribed substance;
• Her use of the prescribed medication was consistent with the concentration found in her sample;

Therefore the AFLD decides on 3 February 2016 for the acquittal of the Athlete.

On 25 August 2015 the French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (FFHMFAC) Disciplinary Panel decided to impose a 3 year period of ineligibility on the Athlete after he tested positive for the prohibited substances Clenbuterol and Stanozolol. 

Thereupon the French Anti-Doping Agency (AFLD) reopened the case against the Athlete. Following notification the Athlete filed a statement in his defence and he was heard.

The Athlete denied the intentional use of the substances and claimed that was the victim of sabotage of his water bottle. Further he alleged that his rights had been violationed due to he was not notified about the postive test in July 2015.

The AFLD determines that:

• The Athlete committed an anti-doping rule violation;
• He failed to demonstrate with corroborating evidence that he was the victim of sabotage;
• He was duly notified about the positive test in July 2015;
• Oral ingestion of Stanozolol with water is immiscible;
• Use of both substances potentiate their enhancing effects.

Therefore the AFLD decides on 3 February 2016 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the notification, i.e. on 8 July 2015.